The West Blog

Latest Blogs

As drug manufacturers aim for higher safety standards and enhanced patient care, controlling the drug product at the point-of-use in a hospital or clinical environment remains a significant challenge. The method of vial access often varies, increasing the risk of adverse patient outcomes, such as stopper cores or fragments entering the drug product. If injected, these fragments can lead to cardiovascular events and other complications. Several factors contribute to stopper coring and fragmentation in the field, primarily influenced by the technique of the practitioner and the properties of the elastomeric closure.

Sanjeev Seenath

July 09, 2025

Select a sub-category to view results

Films and Coatings

Pharmaceutical Packaging Components

Prefillable Systems

Self Injection Devices

Vial Containment Solutions

Washing and Sterilization

Reconstitution and Transfer Devices

Select a sub-category to view results

Analytical Lab Services

Contract Manufacturing

Fill-Finish

Regulatory Support

Select a sub-category to view results

Cell and Gene Therapy Packaging

Drug Development Process

Regulatory Challenges

Transitioning to Combination Products

Select a sub-category to view results

Corporate Development

ESG/Sustainability

One West Team (Employee Culture)

Our Culture of Giving (Philanthropy)

Research and Development

Previous Blogs

HBA Luminary, Iris Bavaj with Karen Flynn and Laura Stankunas

Iris Bavaj named West’s Healthcare Businesswomen’s Association (HBA) Luminary

By West's Global Communications Team

May 12, 2016

We are pleased to announce that Iris Bavaj, Senior Director, Quality Operations, Europe, has been recognized by the Healthcare Businesswomen’s Association (HBA) as West’s 2016 Luminary.

The 2015 Internship Program—a Success for all Involved

By Sarah Gassmann

July 31, 2015

The final week of the Ambassador Internship program is coming to a close, and the 31 students who have been hard at work since June now have the opportunity to showcase what they have learned and reflect upon the entire experience during the program wrap-up.

Eric Green will serve as Chief Executive Officer of West Pharmaceutical Services, Inc. starting today

By West's Global Communications Team

April 24, 2015

Eric Green joins West from Sigma-Aldrich Corporation, where he served as Executive Vice President and President for the Research Markets Business Unit from 2013-2015. This business unit offers research products to scientists in life science, academic, government and hospital settings around the world.

Blogs

Categories

Products

Services

Challenges

About West

Select a sub-category to view results

Films and Coatings

Pharmaceutical Packaging Components

Prefillable Systems

Self Injection Devices

Vial Containment Solutions

Washing and Sterilization

Reconstitution and Transfer Devices

Select a sub-category to view results

Analytical Lab Services

Contract Manufacturing

Fill-Finish

Regulatory Support

Select a sub-category to view results

Cell and Gene Therapy Packaging

Drug Development Process

Regulatory Challenges

Transitioning to Combination Products

Select a sub-category to view results

Corporate Development

ESG/Sustainability

One West Team (Employee Culture)

Our Culture of Giving (Philanthropy)

Research and Development